The procedure, led by Dr. Marc Jeschke, marks the first time exosome therapy has been used to treat human burn injuries. These tiny cellular particles function as biological messengers, coordinating tissue regeneration and reducing inflammation far more effectively than standard surgical grafts. For Jeffrey, a student at Western University, the therapy offered a chance to avoid the patch-like scarring that often accompanies reconstructive surgery on the face and neck.

Dr. Jeschke, a burn surgeon and professor at McMaster University, secured authorization from Health Canada on compassionate grounds to perform the treatment. While exosome therapy has previously shown potential in wound healing trials, its application in acute burn care represents a significant departure from current clinical standards. Jeffrey underwent two separate treatments, resulting in a healing process that surgeons describe as remarkable. The patient noted that the aesthetic improvement has been instrumental in her ongoing recovery, both physically and mentally. The team at the Hamilton General Hospital Centre for Burn Research now aims to gather further evidence, hoping to establish this innovative approach as a new standard for burn care across Canada.